NEW (deerfield)
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Reports Second Quarter 2025 Financial Results & Business Update
Xenon to Report Q2 2025 Financial Results on August 11, 2025